JP2010535180A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535180A5 JP2010535180A5 JP2010518711A JP2010518711A JP2010535180A5 JP 2010535180 A5 JP2010535180 A5 JP 2010535180A5 JP 2010518711 A JP2010518711 A JP 2010518711A JP 2010518711 A JP2010518711 A JP 2010518711A JP 2010535180 A5 JP2010535180 A5 JP 2010535180A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- benzodioxol
- formula
- meo
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CN(C(*)=NC1=C*)C1=O Chemical compound CN(C(*)=NC1=C*)C1=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705632A FR2919608B1 (fr) | 2007-08-01 | 2007-08-01 | Derives d'imidazolones,procede de preparation et applications biologiques |
| FR0705632 | 2007-08-01 | ||
| PCT/FR2008/001152 WO2009050352A2 (fr) | 2007-08-01 | 2008-08-01 | Derives d'imidazolones, procede de preparation et applications biologiques |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010535180A JP2010535180A (ja) | 2010-11-18 |
| JP2010535180A5 true JP2010535180A5 (enExample) | 2014-07-10 |
| JP5926885B2 JP5926885B2 (ja) | 2016-05-25 |
Family
ID=39323606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518711A Expired - Fee Related JP5926885B2 (ja) | 2007-08-01 | 2008-08-01 | イミダゾロン誘導体、その調製方法およびその生物学的使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8563588B2 (enExample) |
| EP (1) | EP2185547B1 (enExample) |
| JP (1) | JP5926885B2 (enExample) |
| KR (1) | KR20100051698A (enExample) |
| CN (1) | CN101784542B (enExample) |
| BR (1) | BRPI0814457A2 (enExample) |
| CA (1) | CA2694377A1 (enExample) |
| ES (1) | ES2644087T3 (enExample) |
| FR (1) | FR2919608B1 (enExample) |
| MX (1) | MX2010001170A (enExample) |
| RU (1) | RU2491283C2 (enExample) |
| WO (1) | WO2009050352A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10316000B2 (en) | 2009-02-18 | 2019-06-11 | Cornell University | Coupled recognition/detection system for in vivo and in vitro use |
| EP2281824A1 (en) | 2009-08-07 | 2011-02-09 | Noscira, S.A. | Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| WO2013016694A2 (en) | 2011-07-27 | 2013-01-31 | Cornell University | Methods for rna detection and quantification |
| JP5910976B2 (ja) * | 2012-07-30 | 2016-04-27 | 国立大学法人京都大学 | 精神神経疾患又は悪性腫瘍に関する化合物及び医薬組成物 |
| FR3002044A1 (fr) * | 2013-02-08 | 2014-08-15 | Centre Nat Rech Scient | Marqueur dyrk1a pour la maladie d'alzheimer |
| CN106061258A (zh) * | 2013-08-29 | 2016-10-26 | 弗吉尼亚联邦大学 | 制造2‑卤代烟腈的方法 |
| US9664676B2 (en) | 2013-09-06 | 2017-05-30 | Cornell University | RNA sequences that induce fluorescence of small molecule fluorophores |
| CN104370891B (zh) * | 2014-10-17 | 2016-09-07 | 中国农业大学 | 一种5-(丁烯内酯-3-亚乙基)-2-氨基咪唑啉酮类化合物、制备方法及其应用 |
| RU2730550C1 (ru) * | 2019-05-15 | 2020-08-24 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Производное 2-селеноксо-тетрагидро-4н-имидазол-4-она, способ его получения и применения |
| WO2021114314A1 (en) * | 2019-12-14 | 2021-06-17 | Tongji University | Novel heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases |
| JP7559082B2 (ja) * | 2019-12-14 | 2024-10-01 | シャンハイ イースト ホスピタル（イースト ホスピタル，トンジ ユニバーシティ スクール オブ メディシン） | 心臓病の治療のための心筋細胞増殖活性を有する複素環式誘導体の使用 |
| KR102491260B1 (ko) * | 2019-12-26 | 2023-01-27 | 연세대학교 산학협력단 | 피롤리딘 유도체 및 이를 포함하는 베타-아밀로이드 또는 타우 단백질 관련 질병의 예방 또는 치료용 약학 조성물 |
| WO2021219828A1 (en) * | 2020-04-30 | 2021-11-04 | Perha Pharmaceuticals | New imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4 |
| EP3904354A1 (en) | 2020-04-30 | 2021-11-03 | Perha Pharmaceuticals | New imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4 |
| EP4173673A1 (en) | 2021-10-26 | 2023-05-03 | Perha Pharmaceuticals | Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4 |
| EP4173675A1 (en) | 2021-10-26 | 2023-05-03 | Perha Pharmaceuticals | Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4 |
| EP4173674A1 (en) | 2021-10-26 | 2023-05-03 | Perha Pharmaceuticals | Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4 |
| WO2025069008A1 (en) | 2023-09-28 | 2025-04-03 | Graviton Bioscience Bv | Therapy for treating type 1 diabetes using rock2 and dyrk1 inhibitors |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1038050B (de) * | 1955-11-17 | 1958-09-04 | Farmaceutici Italia S A Soc | Verfahren zur Herstellung von 5-(3', 4'-Dioxybenzyliden)-Derivaten heterocyclischer Verbindungen |
| US4431656A (en) * | 1981-02-05 | 1984-02-14 | Kanegafuchi Chemical Industry Company Limited | 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient |
| GR79384B (enExample) * | 1982-08-20 | 1984-10-22 | Hoechst Uk Ltd | |
| IE940525L (en) * | 1988-05-25 | 1989-11-25 | Warner Lambert Co | Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents |
| EP0422900B1 (en) * | 1989-10-09 | 1994-03-16 | Kabushiki Kaisha Toshiba | Organic nonlinear optical material and nonlinear optical element |
| US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
| PL166269B1 (pl) * | 1990-04-27 | 1995-04-28 | Orion Yh Tyma Oy | Sposób wytwarzania nowych farmakologicznie aktywnych pochodnych katecholul PL PL PL PL PL |
| JP3015702B2 (ja) * | 1995-02-21 | 2000-03-06 | 株式会社アラクス | イミダゾール誘導体及びそれらの薬剤として許容される酸付加塩及びその製造法並びにそれらを有効成分とする抗潰瘍剤 |
| US6218437B1 (en) * | 1996-09-30 | 2001-04-17 | The Regents Of The University Of California | Treatment and prevention of hepatic disorders |
| PL187019B1 (pl) * | 1997-02-19 | 2004-04-30 | Univ Jagiellonski Collegium Me | Nowe związki, pochodne 5-arylideno-4-okso-2-imidazolidynoglicyny |
| EG21566A (en) * | 1999-09-21 | 2001-12-31 | Hosny Hamed Hoharam | Synthesis of 5-(4-dimethylaminobenzli-dene)-2-phenylhydrozino (1,3-h) imidazole-4-one (iii) |
| WO2004052373A1 (en) * | 2002-12-06 | 2004-06-24 | Warner-Lambert Company Llc | Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k |
| FR2855755B1 (fr) * | 2003-06-05 | 2007-09-07 | Oreal | Utilisation d'au moins un filtre de la lumiere bleue pour preserve le capital de carotenoides endogenes de la peau; nouveaux filtres de la lumiere bleue; compositions cosmetiques |
| ES2328146T3 (es) * | 2003-07-28 | 2009-11-10 | Merck Serono Sa | 2-imino-4-(tio)oxo-5-policiclovinilazolinas para su uso como inhibidores de p13 quinasas. |
| RU2405781C2 (ru) * | 2004-10-14 | 2010-12-10 | Ф.Хоффманн-Ля Рош Аг | 1, 5-нафтиридиназолидиноны, обладающие cdk1 антипролиферативной активностью |
| WO2006105237A2 (en) * | 2005-03-29 | 2006-10-05 | The University Of Maryland, Baltimore | Inhibitors for extracellular signal-regulated kinase docking domains and uses therefor |
| US7304074B2 (en) * | 2005-04-05 | 2007-12-04 | Hoffmann-La Roche Inc. | Substituted 1,5-naphthyridine azolinones |
| JP2007063444A (ja) * | 2005-08-31 | 2007-03-15 | Tdk Corp | 錯化合物及びこれを用いた光記録媒体 |
| US7371862B2 (en) * | 2005-11-11 | 2008-05-13 | Pfizer Italia S.R.L. | Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| US20080280920A1 (en) * | 2005-12-07 | 2008-11-13 | Trifonov Latchezar S | Plasminogen Activator Inhibitor-1 Inhibitors |
-
2007
- 2007-08-01 FR FR0705632A patent/FR2919608B1/fr active Active
-
2008
- 2008-08-01 KR KR1020107004568A patent/KR20100051698A/ko not_active Ceased
- 2008-08-01 CN CN200880103961.8A patent/CN101784542B/zh active Active
- 2008-08-01 JP JP2010518711A patent/JP5926885B2/ja not_active Expired - Fee Related
- 2008-08-01 RU RU2010107262/04A patent/RU2491283C2/ru active
- 2008-08-01 US US12/452,940 patent/US8563588B2/en not_active Expired - Fee Related
- 2008-08-01 MX MX2010001170A patent/MX2010001170A/es active IP Right Grant
- 2008-08-01 CA CA2694377A patent/CA2694377A1/fr not_active Abandoned
- 2008-08-01 EP EP08838929.1A patent/EP2185547B1/fr active Active
- 2008-08-01 WO PCT/FR2008/001152 patent/WO2009050352A2/fr not_active Ceased
- 2008-08-01 BR BRPI0814457-5A2A patent/BRPI0814457A2/pt not_active IP Right Cessation
- 2008-08-01 ES ES08838929.1T patent/ES2644087T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010535180A5 (enExample) | ||
| JP2009524691A5 (enExample) | ||
| RU2010107262A (ru) | Производные имидазолонов, способ получения и биологические применения | |
| JP2007504139A5 (enExample) | ||
| JP2019014758A5 (enExample) | ||
| JP2010509375A5 (enExample) | ||
| JP2018519323A5 (enExample) | ||
| CY1118390T1 (el) | Θεραπευτικος παραγων για τη φλεγμονωδη νοσο του εντερου | |
| JP2007504241A5 (enExample) | ||
| JP2006504658A5 (enExample) | ||
| RU2005123485A (ru) | Производные фосфонооксихиназолина и их фармацевтическое применение | |
| RU2006109599A (ru) | Гетероциклические ингибиторы мек и способы их применения | |
| JP2005504042A5 (enExample) | ||
| CY1112326T1 (el) | Παραγωγα της 6-(πυριδινυλ)-4-πυριμιδονης ως αναστολεις της κινασης 1 tau πρωτεϊνης | |
| JP2017537882A5 (enExample) | ||
| MY150289A (en) | Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof | |
| JP2015506985A5 (enExample) | ||
| JP2008510828A5 (enExample) | ||
| JP2012510502A5 (enExample) | ||
| JP2011506274A5 (enExample) | ||
| JP2012508251A5 (enExample) | ||
| JP2007504235A5 (enExample) | ||
| RU2006120078A (ru) | Производные фосфиновой кислоты, ингибиторы бета-секретазы, предназначенные для лечения болезни альцгеймера | |
| JP2018507230A5 (enExample) | ||
| JP2007500734A5 (enExample) |